Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?
about
Atherosclerosis and infection: is the jury still not in?Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatmentAssociation of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysisAcute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapyHIV infection and cardiovascular diseaseArterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?HIV infection and the risk of acute myocardial infarction.Cardiovascular Complications of HIV-Associated Immune DysfunctionThe roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionFifteen-Year Trends in the Prevalence of Diabetes among Hospitalized HIV-Infected Patients in Spain (1997-2012)Myocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitorsComparison of two drug safety signals in a pharmacovigilance data mining framework.Use of observational data in evaluating treatments: antiretroviral therapy and HIV.Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions.The Role of Caveolin 1 in HIV Infection and Pathogenesis.Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study.Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE)Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western KenyaEpidemiology of coronary heart disease in patients with human immunodeficiency virusAdverse outcome analyses of observational data: assessing cardiovascular risk in HIV diseaseLarge vessel adventitial vasculitis characterizes patients with critical lower limb ischemia with as compared to without human immunodeficiency virus infectionHIV infection, inflammation, immunosenescence, and aging.Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.Immunologic basis of cardiovascular disease in HIV-infected adults.Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic reviewImmune dysregulation and vascular risk in HIV-infected patients: implications for clinical care.Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection.The macrophage: the intersection between HIV infection and atherosclerosis.HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients.HIV infection in the elderlyInsulin resistance in HIV-related lipodystrophy.Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease.Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular diseaseSubclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda.Comparison of Rates of Death Having any Death-Certificate Mention of Heart, Kidney, or Liver Disease Among Persons Diagnosed with HIV Infection with those in the General US Population, 2009-2011Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.
P2860
Q22241306-A8D5F5AE-20D5-4202-B838-4015AFE15A6FQ24802369-40011DF8-066D-407F-914E-9345C0374360Q24803596-C674746E-83C4-44E7-8016-86D57CE10D28Q27000959-F6B9CEC4-2AC5-4A81-96B0-A015BB26FB89Q27008328-674B7257-3EF7-4AA6-9849-5E95E39769BDQ27008915-A376C45F-621A-4E97-BC1B-B988C227FB96Q27026486-193E72C4-15F9-4554-9272-0E2C4BF9D78DQ27347231-50F7F512-0C2E-494A-8138-B9165BF84F71Q28084981-DF041077-3F50-405C-93F2-729E23FBEE04Q28386344-5A646BD8-013C-45C0-A6EF-48196A102070Q28553878-D52D2B2E-EDEA-4B19-9954-3C7CF956407EQ28743987-3784E3E7-843A-4769-BD7B-9FBBB54815E0Q30573571-6C4ACE81-A96D-4121-A732-CE8D1B9C2595Q30969932-85620739-3E11-452C-887E-E34D20590A16Q31034655-073E2BCF-E858-4E3F-8845-58CEF9106AA0Q32183747-32BDFC6D-3A40-4525-9F45-56644CC5AA9FQ33262244-53D8F87E-363D-4D02-B1F2-313D90AE29ADQ33761167-800B204E-6A30-4498-97EF-37FE05A1CA47Q33927532-4DF70038-F831-41B3-AB36-64C18716E365Q33944936-9710682D-9900-4B9C-BD68-EE8115E799D1Q33968354-7CACFBB3-6BE6-40C5-8F7F-5B462F5E291BQ33998067-02EAEE8A-4AB8-4DC8-8663-BCBE9545AADFQ34077477-C67A29B1-AB5C-45DB-91FC-77EF12C0C066Q34110470-79F9A398-61AC-4E8F-A0EB-FD3CE7D8C0ECQ34150710-7237E614-92F3-4B7D-9C08-536E200F41B8Q34315579-57BA668A-0C91-4FDC-8859-7F314A88769FQ34638205-ACFD29B8-92DF-4AED-9A8F-AAA63882829DQ34651525-7B8C8BE3-2064-486E-A923-A548BF2B829FQ34764372-C4F4316F-6BD2-4EDF-AC24-2062D0E73EBDQ34796153-916BE917-A338-4FAB-9586-B955A53885E3Q34898069-7DBDF2BB-B9D6-498C-9E96-7C337862E567Q35068359-9EE461C3-ADD3-4F1A-9206-AABBF9DB21DBQ35072103-E8FBDBCB-3088-4070-8331-7456529BAC81Q35086332-25C77E6C-ABF1-4784-81B6-81BC63781B0BQ35087005-0275BA3F-716D-46DC-A86E-91484DACED3AQ35089263-E9BF5117-386E-406D-AEBB-C13B69ADD49DQ35104006-FCD255E5-0A57-4DEF-9868-225EEF7CB809Q35107571-B54FC79F-70E1-47B0-8B16-61A00093F2E0Q35157763-25995892-C6A1-4158-82A0-6D2529587A30Q35160580-7F071598-5EBB-449F-BCED-505EDCCE0A9E
P2860
Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Do protease inhibitors increas ...... patients with HIV-1 infection?
@ast
Do protease inhibitors increas ...... patients with HIV-1 infection?
@en
type
label
Do protease inhibitors increas ...... patients with HIV-1 infection?
@ast
Do protease inhibitors increas ...... patients with HIV-1 infection?
@en
prefLabel
Do protease inhibitors increas ...... patients with HIV-1 infection?
@ast
Do protease inhibitors increas ...... patients with HIV-1 infection?
@en
P2093
P1476
Do protease inhibitors increas ...... patients with HIV-1 infection?
@en
P2093
Charles P Quesenberry
Daniel Klein
Leo B Hurley
Stephen Sidney
P304
P356
10.1097/00126334-200208150-00002
P407
P577
2002-08-01T00:00:00Z